Nefopam HCl Injectable
Moderate to Severe Pain
ApprovedActive
Key Facts
About Ethypharm
Ethypharm is a France-based, private specialty pharma company with nearly five decades of operation, specializing in drug delivery and essential medicines. It has established a clear strategic focus on the Central Nervous System (CNS) for severe pain and addiction, and on Hospital Injectables, leveraging its manufacturing and commercial capabilities. The company is in a commercial, revenue-generating stage, actively growing its portfolio through in-licensing and geographic expansion, particularly in Europe's top five markets and China. Its business model is centered on developing, manufacturing, and commercializing therapeutics, with a stated ambition to address unmet needs in its core areas.
View full company profileTherapeutic Areas
Other Moderate to Severe Pain Drugs
| Drug | Company | Phase |
|---|---|---|
| Nyloxin® / Nyloxin Extra Strength® | Nutra Pharma | Marketed |